Literature DB >> 3084615

Rapid changes in plasma androgens during insulin withdrawal in male type 1 (insulin-dependent) diabetics.

S Madsbad, C Gluud, P Bennett, T Krarup.   

Abstract

Plasma concentrations of testosterone, androstenedione and dihydrotestosterone were measured in 15 Type 1 (insulin-dependent) diabetics with (n = 8) and without (n = 7) B-cell function during 12 h of insulin withdrawal and compared with those of 8 normal subjects. Before insulin withdrawal no significant difference was found in androgen concentrations between the diabetic and the normal subjects. The normal diurnal profiles, with highest androgen concentrations in the morning before insulin withdrawal (08:00) and lowest concentrations at 20:00 h were maintained in the diabetics. However, testosterone and dihydrotestosterone concentrations were lower in the diabetics after 4 h of insulin withdrawal and remained so throughout the study. The concentrations of androstenedione were not significantly different between diabetics and normal subjects except after 4 h of insulin withdrawal. Despite the patients without B-cell function were more metabolically decompensated from after 4 h of insulin withdrawal compared with patients with B-cell function, no significant differences were found in androgen concentrations between the two groups although a tendency to lower concentrations were seen in the group without B-cell function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084615     DOI: 10.1007/BF03348056

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Methods for multiple steroid radioimmunoassay.

Authors:  C R Parker; J O Ellegood; V B Mahesh
Journal:  J Steroid Biochem       Date:  1975-01       Impact factor: 4.292

2.  Sexual dysfunction in diabetic men.

Authors:  R C Kolodny; C B Kahn; H H Goldstein; D M Barnett
Journal:  Diabetes       Date:  1974-04       Impact factor: 9.461

3.  Critical illness and low testosterone: effects of human serum on testosterone transport into rat brain and liver.

Authors:  O S Goussis; W M Pardridge; H L Judd
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

4.  Plasma testosterone and androstenedione in insulin dependent patients at time of diagnosis and during the first year of insulin treatment.

Authors:  C Gluud; S Madsbad; T Krarup; P Bennett
Journal:  Acta Endocrinol (Copenh)       Date:  1982-07

5.  C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.

Authors:  O K Faber; C Binder
Journal:  Diabetes       Date:  1977-07       Impact factor: 9.461

6.  Effects of general anaesthesia and severity of surgical stress on serum LH and testosterone in males.

Authors:  A Nakashima; K Koshiyama; T Uozumi; Y Monden; Y Hamanaka
Journal:  Acta Endocrinol (Copenh)       Date:  1975-02

7.  Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity.

Authors:  J P Deslypere; A Vermeulen
Journal:  J Clin Endocrinol Metab       Date:  1984-11       Impact factor: 5.958

8.  Non-glucoregulatory hormones (T4, T3, rT3, TSH, testosterone) during physical exercise in juvenile type diabetics.

Authors:  P Berchtold; M Berger; H J Cüppers; J Herrmann; E Nieschlag; K Rudorff; H Zimmermann; H L Krüskemper
Journal:  Horm Metab Res       Date:  1978-07       Impact factor: 2.936

9.  Diabetic sexual dysfunction: a comparative study of 160 insulin treated diabetic men and women and an age-matched control group.

Authors:  S B Jensen
Journal:  Arch Sex Behav       Date:  1981-12

10.  Effect of insulin antibodies on free and total plasma-insulin.

Authors:  A B Kurtz; B E Mustaffa; P R Daggett; J D Nabarro
Journal:  Lancet       Date:  1977-07-09       Impact factor: 79.321

View more
  3 in total

Review 1.  The effects of type 1 diabetes on the hypothalamic, pituitary and testes axis.

Authors:  Erica L Schoeller; Samantha Schon; Kelle H Moley
Journal:  Cell Tissue Res       Date:  2012-04-15       Impact factor: 5.249

2.  Cancer risk in patients with diabetes mellitus.

Authors:  H O Adami; J McLaughlin; A Ekbom; C Berne; D Silverman; D Hacker; I Persson
Journal:  Cancer Causes Control       Date:  1991-09       Impact factor: 2.506

3.  Diabetes mellitus and risk of prostate cancer: a meta-analysis.

Authors:  S Bonovas; K Filioussi; A Tsantes
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.